Page last updated: 2024-08-21

malondialdehyde and apremilast

malondialdehyde has been researched along with apremilast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Anazi, WA; Al-Asmari, AF; Al-Harbi, MM; Al-Harbi, NO; Almutairi, MM; Alotaibi, MR; Alsaad, AM; Alshammari, M; Ansari, MA; Ansari, MN; Bahashwan, S; Imam, F; Khan, MR	1

Other Studies

1 other study(ies) available for malondialdehyde and apremilast

Article	Year
Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways. Pharmacological reports : PR, 2018, Volume: 70, Issue:5 Topics: Animals; Apoptosis; Cardiotoxicity; Caspase 3; Catalase; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Glutathione Reductase; Inflammation; Male; Malondialdehyde; Myocardium; NF-kappa B; Oxidative Stress; Rats; RNA, Messenger; Signal Transduction; Thalidomide	2018

Article

Year

Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways.

Pharmacological reports : PR, 2018, Volume: 70, Issue:5

Topics: Animals; Apoptosis; Cardiotoxicity; Caspase 3; Catalase; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Glutathione Reductase; Inflammation; Male; Malondialdehyde; Myocardium; NF-kappa B; Oxidative Stress; Rats; RNA, Messenger; Signal Transduction; Thalidomide

2018